ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir
in combination with chemoradiation for locally advanced inoperable
pancreatic cancer

ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer

Background and purpose Nelfinavir can enhance intrinsic radiosensitivity, reduce hypoxia and improve vascularity. We conducted a phase II trial combining nelfinavir with chemoradiotherapy (CRT) for locally advanced inoperable pancreatic cancer (LAPC). Materials and methods Radiotherapy (50.4 Gy/28...

Detaylı Bibliyografya
Asıl Yazarlar:	Wilson, J, Fokas, E, Dutton, S, Hawkins, M, al., E
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	Elsevier 2016

Benzer Materyaller

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
Yazar:: Wilson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
Yazar:: Brunner, T, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
Yazar:: Brunner, T, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.
Yazar:: Brunner, T, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

HIV-1 genotypes related to failure of nelfinavir as the first protease inhibitor treatment
Yazar:: Unaí Tupinambás, ve diğerleri

New insights into the in silico prediction of HIV protease resistance to nelfinavir.
Yazar:: Dinler A Antunes, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir
Yazar:: Chao Ying, ve diğerleri
Baskı/Yayın Bilgisi: (2008-02-01)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
Yazar:: Holyoake, D, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
Yazar:: Crosby, T, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
Yazar:: Anjali K. Gupta, ve diğerleri
Baskı/Yayın Bilgisi: (2007-04-01)

Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes.
Yazar:: Pranav Kumar, ve diğerleri
Baskı/Yayın Bilgisi: (2010-03-01)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
Yazar:: Mukherjee, S, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein
Yazar:: Zhongli Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Pneumocephalus after the Treatment of an Inoperable Superior Sulcus Tumor with Chemoradiation
Yazar:: Ashley Albert, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

The impact of the nelfinavir resistance-conferring mutation D30N on the susceptibility of HIV-1 subtype B to other protease inhibitors
Yazar:: André FA Santos, ve diğerleri
Baskı/Yayın Bilgisi: (2011-03-01)

SCALOP-2: A randomised trial of induction GEMABX followed by chemoradiation (high/standard dose radiation) +/-nelfinavir for locally advanced pancreatic cancer: results of the dose-finding component
Yazar:: Mukherjee, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
Yazar:: Al-Assar, O, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial
Yazar:: Sudeep Gupta, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
Yazar:: Fokas, E, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
Yazar:: Steffi Liebscher, ve diğerleri
Baskı/Yayın Bilgisi: (2017-02-01)

THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
Yazar:: E. P. Solov’eva, ve diğerleri
Baskı/Yayın Bilgisi: (2016-02-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
Yazar:: Christoph Driessen, ve diğerleri
Baskı/Yayın Bilgisi: (2016-03-01)

The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
Yazar:: V. B. Denisenko,, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

Chemoradiation of pancreatic carcinoma
Yazar:: Erdinç Nayır, ve diğerleri
Baskı/Yayın Bilgisi: (2016-08-01)

Nelfinavir and Non-Nucleoside Reverse Transcriptase Inhibitor-Based Salvage Regimes in Heavily Hiv Pretreated Patients
Yazar:: Jean-Guy Baril, ve diğerleri
Baskı/Yayın Bilgisi: (2003-01-01)

The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo
Yazar:: Camille Bono, ve diğerleri
Baskı/Yayın Bilgisi: (2012-07-01)

Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation
Yazar:: Hilario Yankey, MD, MBA, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Combination of chemoradiation therapy with immunotherapy in the treatment of patients with inoperable stage III non-small cell lung cancer
Yazar:: N. V. Marinichenko, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Spectrophometric Determination of Nelfinavir Mesylate
Yazar:: K. Vanitha Prakash, ve diğerleri
Baskı/Yayın Bilgisi: (2006-01-01)

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study
Yazar:: Alison K. Yoder, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

ACCELEREATED HYPERFRACTIONATED WITH UNEVEN CRUSHING DAILY DOSE WITH CHEMORADIATION TREATMENT OF INOPERABLE NON-SMALL CELL LUNG CANCER.
Yazar:: D. V. Gogolin, ve diğerleri
Baskı/Yayın Bilgisi: (2016-02-01)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
Yazar:: Léon Juan, ve diğerleri
Baskı/Yayın Bilgisi: (2006-07-01)

Induction of Suicidal Erythrocyte Death by Nelfinavir
Yazar:: Rosi Bissinger, ve diğerleri
Baskı/Yayın Bilgisi: (2015-05-01)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
Yazar:: Lenka Besse, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Nelfinavir: An Old Ally in the COVID-19 Fight?
Yazar:: Anna Gidari, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
Yazar:: Serena Veschi, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
Yazar:: Kang Young-Nam, ve diğerleri
Baskı/Yayın Bilgisi: (2010-06-01)

Clinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancer
Yazar:: Hill, E, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.
Yazar:: Tinkl, D, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
Yazar:: Camacho Ricardo J, ve diğerleri
Baskı/Yayın Bilgisi: (2010-08-01)